FILTER
FILTERED INTERVIEW RESULTS
Eugene Williams
EXECUTIVE CHAIRMAN, PROMIS
ProMIS Neurosciences is a development-stage biotech company focused on neurodegenerative diseases, particularly Alzheimer’s disease and ALS.
Wu Yifang
CEO, FOSUN PHARMA
Fosun Pharma is a leading pharma company in China with innovative and global ambitions.
Sara Radcliffe
PRESIDENT & CEO, CALIFORNIA LIFE SCIENCES ASSOCIATION
California Life Sciences Association (CLSA) is the trade association representing California’s in-novative life sciences industry, ensuring that it retains its competitive edge.
Dr. Jim Li
CEO, SUNDIA
Sundia is a CRO based in China and speaks to GBR of the evolution of the drug discovery process in China.
Dr. Xu Jia
CONSULTING LEADER, PWC CHINA HEALTHCARE AND PHARMACEUTICALS
PwC in China is benefitting from the rise of the biopharma and a flurry of IPO and acquisition activities in the pharma industry more generally.
Nick Grasman
LEAD MARKET MANAGER, DOW PHARMA SOLUTIONS, THE DOW CHEMICAL COMPANY
Dow Pharma Solutions develops functional excipients and APIs that enable improved pharmaceutical delivery and enhanced solubility.
Jay Dong
GENERAL MANAGER and GLOBAL VP, CST CHINA
CST is expanding its footprint across China where R&D and innovation spending is on the rise.
Mickey Kertesz
FOUNDER & CEO, KARIUS
The Karius test harnesses next-generation sequencing to detect fragments of cell-free DNA from bacteria, viruses, fungi and protozoa that may be circulating in a patient’s bloodstream.
William Hait
GLOBAL HEAD, JOHNSON & JOHNSON GLOBAL EXTERNAL INNOVATION
Johnson & Johnson invested US$10 billion in research and development in 2017 both internally and externally.
Jonathan Zhu
PARTNER PRACTICE LEADER, CHINA LIFE SCIENCE & GOVERNMENT AFFAIRS, HEIDRICK & STRUGGLES
H&S is one of the top five recruiting firms globally and is expanding its services in China’s rapidly growing life science sector.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Mexico Chemicals 2024
In August 2023, Mexican exports to the US surpassed China for the first time. As companies prioritize securing supply their chains after years of logistics challenges, Mexico has begun to see major benefits. With a spate of new infrastructure projects such as the Interoceanic Corridor of the Isthmus of Tehuantepec coming online in 2023, the country is actively opening itself to investment. The chemical industry, in particular, is positioned for nearshoring-driven growth.
In August 2023, Mexican exports to the US surpassed China for the first time. As companies prioritize securing supply their chains after years of logistics challenges, Mexico has begun to see major benefits. With a spate of new infrastructure projects such as the Interoceanic Corridor of the Isthmus of Tehuantepec coming online in 2023, the country is actively opening itself to investment. The chemical industry, in particular, is positioned for nearshoring-driven growth.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
